Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

Medicare parts B and D may cover Humira, including home injections and the drug itself in certain cases. Some programs may help with costs. Learn more here.

Get the facts on Humira’s dosages. You can also learn how to use the drug, which forms it comes in, and more.

AbbVie's Rinvoq and Skyrizi could eventually surpass Humira's peak sales. The dividend is well-funded, though an expensive acquisition spree may lead to slower growth. The stock's solid growth ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company, stands at a critical juncture as it navigates the loss of ...

Optimizing Humira coverage. It can perform miracles, and its cost can make benefits managers feel faint. By Cynthia Chioma Nwaubani | March 03, 2025 at 04:16 PM ...

Medicare parts B and D may cover Humira, including home injections and the drug itself in certain cases. Some programs may help with costs. Learn more here.

Blue Shield is teaming up with drugmaker Fresenius Kabi and Evio Pharmacy Solutions to purchase a biosimilar for Humira at a transparent net price of $525 per monthly dose.

Blue Shield of California partners with Fresenius Kabi and Evio Pharmacy to cut the cost of Humira's biosimilar to $525 per month, with most members paying $0 out of pocket starting January 2025.

Humira's patent expired in January 2023, opening the door for lower-cost biosimilars. However, prices haven't decreased as much as expected in a functioning market, limiting widespread adoption.

Tennessee last year spent $48 million on a single drug, Humira—about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.